Life Expectancy of Patients with Aplastic Anemia

The life expectancy of patients with aplastic anemia hinges on a comprehensive evaluation encompassing the severity of the disease, treatment outcomes, and individual physical constitution. Typically, if patients actively collaborate with healthcare professionals in their treatment journey and the disease is of a milder nature, it often does not significantly impact their lifespan.

Mild Condition

1. In cases where the patient's condition is mild, manifested solely as fatigue, dizziness, and devoid of other distressing symptoms, specialized treatment might not be immediately necessary. It is paramount to obtain adequate rest, ensure sufficient sleep, refrain from prolonged periods of wakefulness at night, and maintain a nutritious diet rich in proteins, fresh fruits, and vegetables to replenish the body's essential nutrients.

Severe Condition

2. When the disease assumes a severe form, characterized by skin bleeding points, nasal bleeding, and accompanied by fever, prompt medical attention and treatment become imperative. Neglecting these indicators can precipitate disease progression, posing a threat to life. At this juncture, medications such as Cyclosporine Soft Capsules and Stanozolol Tablets may be prescribed under medical supervision. If deemed necessary, hematopoietic stem cell transplantation can be considered. Patients are advised to undergo regular follow-ups, maintain a positive outlook, and avoid excessive emotional agitation or stress in their daily lives.